855779P
Avanti
22:0 Lyso PC
1-behenoyl-2-hydroxy-sn-glycero-3-phosphocholine, powder
Sign Into View Organizational & Contract Pricing
All Photos(2)
1-docosanoyl-sn-glycero-3-phosphocholine; PC(22:0/0:0)
C30H62NO7P
Recommended Products
Assay
>99% (LPC; may contain up to 10% of the 2-LPC isomer, TLC)
form
powder
packaging
pkg of 1 × 25 mg (855779P-25mg)
manufacturer/tradename
Avanti Polar Lipids 855779P
shipped in
dry ice
storage temp.
−20°C
SMILES string
O[C@](COP([O-])(OCC[N+](C)(C)C)=O)([H])COC(CCCCCCCCCCCCCCCCCCCCC)=O
Application
22:0 Lyso PC may be used as a standard to screen X-linked adrenoleukodystrophy (X-ALD) in newborns using positive ion electrospray (ESI) combined liquid chromatography-tandem spectrometric (LC-MS/MS) technique.
Packaging
5 mL Amber Glass Screw Cap Vial (855779P-25mg)
also commonly purchased with this product
Product No.
Description
Pricing
Certificates of Analysis (COA)
Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Newborn screening for X-linked adrenoleukodystrophy (X-ALD): validation of a combined liquid chromatography-tandem mass spectrometric (LC-MS/MS) method
Molecular Genetics and Metabolism, 97(3), 212-220 (2009)
Molecular genetics and metabolism, 89(1-2), 185-187 (2006-07-11)
Utilizing combined liquid chromatography-tandem mass spectrometry (LC-MS/MS) as the analytical method, we have demonstrated a ten to sixtyfold excess of lysophosphatidyl choline containing hexacosanoic acid (26:0) in dried blood spots on a filter paper matrix from 25 male patients with
Colloids and surfaces. B, Biointerfaces, 186, 110715-110715 (2019-12-17)
A fifteen-components model membrane that reflected the 80 % of phospholipids present in Insulin Secretory Granules was obtained and thermodynamic exploitation was performed, through micro-DSC, in order to assess the synergic contributions to the stability of a mixed complex system
Autophagy, 13(5), 868-884 (2017-05-20)
Peroxisome biogenesis disorders (PBDs) are metabolic disorders caused by the loss of peroxisomes. The majority of PBDs result from mutation in one of 3 genes that encode for the peroxisomal AAA ATPase complex (AAA-complex) required for cycling PEX5 for peroxisomal
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service